Maria Grazia Roncarolo
CIK: 0001811671
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ATRA
Atara Biotherapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About Roncarolo Maria Grazia
Roncarolo Maria Grazia (SEC CIK 0001811671) files insider reports with the SEC as Director of Atara Biotherapeutics, Inc. (ATRA).
Signal8 holds 1 ownership filing by Roncarolo Maria Grazia, a Form 4, filed on Jun 12, 2025. Those filings report 1 transaction, the latest on Jun 10, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Roncarolo Maria Grazia's filings is in THOUSAND OAKS, CA.
Recent filings by Roncarolo Maria Grazia
- Jun 10, 2025: Grant or award of ATRA shares (Form 4, code A).
Other insiders filing for Atara Biotherapeutics, Inc. (ATRA)
- Cherry Brian N, Director
- Nguyen AnhCo, President and CEO
- Redmile Group, LLC, Director
- Sarney Kevin G, Interim CFO
- HEIDEN WILLIAM K, Director
- Fust Matthew K, Director